William J. Kell
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 3
- Multiple Myeloma Research and Treatments 3
- Hematopoietic Stem Cell Transplantation 2
-
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Alan K. Burnett (12 shared papers)Mark J. Levis (1 shared paper)Donald Small (1 shared paper)Steven Knapper (1 shared paper)Tim Littlewood (1 shared paper)Raj Chopra (1 shared paper)Richard E. Clark (1 shared paper)Robert K. Hills (8 shared papers)
- Journals
- Blood (11 papers)Leukemia (1 paper)Hematology (1 paper)ORCA Online Research @Cardiff (Cardiff University) (1 paper)
- Partner nations
- United KingdomUnited StatesHong Kong
In The Last Decade
William J. Kell
14 papers receiving 733 citations
Peers
Comparison fields: 5 of 49
- Hematology 539
- Genetics 160
- Public Health, Environmental and Occupational Health 129
- Molecular Biology 303
- Oncology 110
Countries citing papers authored by William J. Kell
This map shows the geographic impact of William J. Kell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Kell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Kell more than expected).
Fields of papers citing papers by William J. Kell
This network shows the impact of papers produced by William J. Kell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Kell. The network helps show where William J. Kell may publish in the future.
Co-authors
The 25 scholars most cited alongside William J. Kell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 332 | |
| 2 | 2003 | 154 | |
| 3 | 2012 | 127 | |
| 4 | 2006 | 66 | |
| 5 | 2005 | 35 | |
| 6 | 2011 | 19 | |
| 7 | 2006 | 9 | |
| 8 | 2010 | 5 | |
| 9 | 2003 | 5 | |
| 10 | 2008 | 3 | |
| 11 | Myelodysplastic bone marrow stroma is defective in its ability to sustain normal stem cell growth | 1997 | 3 |
| 12 | 2023 | 2 | |
| 13 | 2006 | 2 | |
| 14 | 2009 | 1 |
About William J. Kell
William J. Kell is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Organic Chemistry and Genetics, having authored 14 papers that have together received 763 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Click Chemistry and Applications (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Synthesis of Tetrazole Derivatives (1 paper). The work is most often cited by research in Hematology (539 citations), Genetics (160 citations), Public Health, Environmental and Occupational Health (129 citations), Molecular Biology (303 citations) and Oncology (110 citations). William J. Kell has collaborated with scholars based in United Kingdom, United States and Hong Kong. Frequent co-authors include Alan K. Burnett, Mark J. Levis, Donald Small, Steven Knapper, Tim Littlewood, Raj Chopra, Richard E. Clark, Robert K. Hills, Nigel H. Russell and Keith Wheatley. Their work appears in journals such as Blood, Leukemia, Hematology and ORCA Online Research @Cardiff (Cardiff University).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.